Does an Aspirin a Day Keep the Cardiovascular Disease Away?

Thursday, December 8, 2022

10:00 AM – 10:45 AM

Location: Mandalay Bay South Convention Center, Mandalay Bay J, Level 2

CE Credits: 0.75 contact hours

Planned in cooperation with the ASHP Section of Clinical Specialists and Scientists
Activity #: 0204-0000-22-347-L01-P
Activity Type: Knowledge-based
Target Audience: Pharmacist

Learning Objectives:

Identify in practice risk factors for the development of cardiovascular disease.
Discuss the evidence for specific antiplatelet therapy to lower cardiovascular risk.
State the role of antiplatelet therapy in preventing cardiovascular disease in primary prevention patients.

Program Chair(s)

Joel C. Marrs, PharmD, MPH, BCACP, BCCP, BCPS, CHC, CLS, FAHA, FASHP, FCCP, FNLA

Professor and Coordinator of Clinical Outreach
The University of Tennessee Health Science Center, Department of Clinical Pharmacy & Translational Science

Moderator(s)

Joel C. Marrs, PharmD, MPH, BCACP, BCCP, BCPS, CHC, CLS, FAHA, FASHP, FCCP, FNLA

Professor and Coordinator of Clinical Outreach
The University of Tennessee Health Science Center, Department of Clinical Pharmacy & Translational Science

Faculty Member(s)

Joel C. Marrs, PharmD, MPH, BCACP, BCCP, BCPS, CHC, CLS, FAHA, FASHP, FCCP, FNLA

Professor and Coordinator of Clinical Outreach
The University of Tennessee Health Science Center, Department of Clinical Pharmacy & Translational Science